Microcap Opportunities

Microcap Opportunities

Share this post

Microcap Opportunities
Microcap Opportunities
NeurAxis On A Path To Profitability

NeurAxis On A Path To Profitability

Sergio Heiber's avatar
Sergio Heiber
Aug 19, 2024
∙ Paid
2

Share this post

Microcap Opportunities
Microcap Opportunities
NeurAxis On A Path To Profitability
Share

NeurAxis (NRXS) is a neuromodulation medical technology company offering IB-Stim therapy that is based on its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. IB-Stim has FDA clearance as the first medical device for functional abdominal pain associated ("FPA") with irritable bowel syndrome ("IBS") in children.

The IB-Stim …

Keep reading with a 7-day free trial

Subscribe to Microcap Opportunities to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 MicroCap Opportunities
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share